183 related articles for article (PubMed ID: 32052315)
21. Platelet reactivity and clinical outcomes in acute coronary syndrome patients treated with prasugrel and clopidogrel: a pre-specified exploratory analysis from the TROPICAL-ACS trial.
Aradi D; Gross L; Trenk D; Geisler T; Merkely B; Kiss RG; Komócsi A; Dézsi CA; Ruzsa Z; Ungi I; Rizas KD; May AE; Mügge A; Zeiher AM; Holdt L; Huber K; Neumann FJ; Koltowski L; Huczek Z; Hadamitzky M; Massberg S; Sibbing D
Eur Heart J; 2019 Jun; 40(24):1942-1951. PubMed ID: 31226213
[TBL] [Abstract][Full Text] [Related]
22. Vitamin D levels and high-residual platelet reactivity in patients receiving dual antiplatelet therapy with clopidogrel or ticagrelor.
Verdoia M; Pergolini P; Rolla R; Sartori C; Nardin M; Schaffer A; Barbieri L; Daffara V; Marino P; Bellomo G; Suryapranata H; De Luca G;
Platelets; 2016 Sep; 27(6):576-82. PubMed ID: 27540959
[TBL] [Abstract][Full Text] [Related]
23. Association between platelet reactivity and circulating platelet-derived microvesicles in patients with acute coronary syndrome.
Kafian S; Mobarrez F; Wallén H; Samad B
Platelets; 2015; 26(5):467-73. PubMed ID: 25025694
[TBL] [Abstract][Full Text] [Related]
24. Sex Differences in the Clinical Impact of High Platelet Reactivity After Percutaneous Coronary Intervention With Drug-Eluting Stents: Results From the ADAPT-DES Study (Assessment of Dual Antiplatelet Therapy With Drug-Eluting Stents).
Yu J; Mehran R; Baber U; Ooi SY; Witzenbichler B; Weisz G; Rinaldi MJ; Neumann FJ; Metzger DC; Henry TD; Cox DA; Duffy PL; Mazzaferri EL; Brodie BR; Stuckey TD; Maehara A; Xu K; Ben-Yehuda O; Kirtane AJ; Stone GW
Circ Cardiovasc Interv; 2017 Feb; 10(2):. PubMed ID: 28193677
[TBL] [Abstract][Full Text] [Related]
25. High post-clopidogrel platelet reactivity assessed by a point-of-care assay predicts long-term clinical outcomes in patients with ST-segment elevation myocardial infarction who underwent primary coronary stenting.
Jin HY; Yang TH; Kim DI; Chung SR; Seo JS; Jang JS; Kim DK; Kim DK; Kim KH; Seol SH; Nam CW; Hur SH; Kim W; Park JS; Kim YJ; Kim DS
Int J Cardiol; 2013 Sep; 167(5):1877-81. PubMed ID: 22682702
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of clinical risk factors to predict high on-treatment platelet reactivity and outcome in patients with stable coronary artery disease (PREDICT-STABLE).
Droppa M; Tschernow D; Müller KA; Tavlaki E; Karathanos A; Stimpfle F; Schaeffeler E; Schwab M; Tolios A; Siller-Matula JM; Gawaz M; Geisler T
PLoS One; 2015; 10(3):e0121620. PubMed ID: 25799149
[TBL] [Abstract][Full Text] [Related]
27. Thrombin-induced platelet-fibrin clot strength: relation to high on-clopidogrel platelet reactivity, genotype, and post-percutaneous coronary intervention outcomes.
Jeong YH; Bliden KP; Shuldiner AR; Tantry US; Gurbel PA
Thromb Haemost; 2014 Apr; 111(4):713-24. PubMed ID: 24336898
[TBL] [Abstract][Full Text] [Related]
28. Pharmacodynamic Effects of Switching From Ticagrelor to Clopidogrel in Patients With Coronary Artery Disease: Results of the SWAP-4 Study.
Franchi F; Rollini F; Rivas Rios J; Rivas A; Agarwal M; Kureti M; Nagaraju D; Wali M; Shaikh Z; Briceno M; Nawaz A; Moon JY; Been L; Suryadevara S; Soffer D; Zenni MM; Bass TA; Angiolillo DJ
Circulation; 2018 Jun; 137(23):2450-2462. PubMed ID: 29526833
[TBL] [Abstract][Full Text] [Related]
29. Impact of gene polymorphisms, platelet reactivity, and the SYNTAX score on 1-year clinical outcomes in patients with non-ST-segment elevation acute coronary syndrome undergoing percutaneous coronary intervention: the GEPRESS study.
Palmerini T; Calabrò P; Piscione F; De Servi S; Cattaneo M; Maffeo D; Toso A; Bartorelli A; Palmieri C; De Carlo M; Capodanno D; Barozzi C; Tomasi L; Della Riva D; Mariani A; Taglieri N; Reggiani LB; Bianchi R; De Rosa R; Mariani M; Podda G; Généreux P; Stone GW; Angiolillo DJ
JACC Cardiovasc Interv; 2014 Oct; 7(10):1117-27. PubMed ID: 25240538
[TBL] [Abstract][Full Text] [Related]
30. Serum uric acid level negatively correlated with the prevalence of clopidogrel low response in patients undergoing antiplatelet treatment with aspirin and clopidogrel.
Wang J; Abdus S; Tan C; Gu Q; Yang M; Wang G; Shi L; Gong X; Li C
Nutr Metab Cardiovasc Dis; 2020 Nov; 30(12):2215-2220. PubMed ID: 32912788
[TBL] [Abstract][Full Text] [Related]
31. Predictors of high on-aspirin platelet reactivity in high-risk vascular patients treated with single or dual antiplatelet therapy.
Amsallem M; Manzo-Silberman S; Dillinger JG; Sideris G; Voicu S; Bal dit Sollier C; Drouet L; Henry P
Am J Cardiol; 2015 May; 115(9):1305-10. PubMed ID: 25759104
[TBL] [Abstract][Full Text] [Related]
32. Platelet reactivity over time in coronary artery disease patients treated with a bioabsorbable everolimus-eluting scaffold.
Tello-Montoliu A; Rivera J; Hernández-Romero D; Silvente A; Jover E; Quintana M; Orenes-Piñero E; Hurtado J; Ferreiro JL; Marín F; Valdés M
Platelets; 2016 Dec; 27(8):777-783. PubMed ID: 27257022
[TBL] [Abstract][Full Text] [Related]
33. Relationship between high platelet reactivity on clopidogrel and long-term clinical outcomes after drug-eluting stents implantation (PAINT-DES): a prospective, propensity score-matched cohort study.
Gao XF; Lu S; Ge Z; Zuo GF; Wang ZM; Wang F; Kong XQ; Chai DY; Chen SL; Zhang JJ
BMC Cardiovasc Disord; 2018 May; 18(1):103. PubMed ID: 29793432
[TBL] [Abstract][Full Text] [Related]
34. The prognostic value of multiple electrode aggregometry and light transmittance aggregometry in stable cardiovascular patients with type 2 diabetes mellitus.
Tsantes AE; Taichert M; Kyriakou E; Katogiannis K; Lytras T; Gialeraki A; Tzoumakidou E; Kokoris S; Douramani P; Kypraiou A; Poulis A; Katsadiotis G; Kalantzis D; Kottaridi C; Kopterides P; Bonovas S; Ikonomidis I
Thromb Res; 2019 Aug; 180():47-54. PubMed ID: 31202191
[TBL] [Abstract][Full Text] [Related]
35. Routine assessment of on-clopidogrel platelet reactivity and gene polymorphisms in predicting clinical outcome following drug-eluting stent implantation in patients with stable coronary artery disease.
Viviani Anselmi C; Briguori C; Roncarati R; Papa L; Visconti G; Focaccio A; De Micco F; Latronico MV; Pagnotta P; Condorelli G
JACC Cardiovasc Interv; 2013 Nov; 6(11):1166-75. PubMed ID: 24262617
[TBL] [Abstract][Full Text] [Related]
36. Suboptimal response to clopidogrel and the effect of prasugrel in acute coronary syndromes.
Johnston LR; Larsen PD; La Flamme AC; Michel JM; Simmonds MB; Harding SA
Int J Cardiol; 2013 Aug; 167(3):995-9. PubMed ID: 22465351
[TBL] [Abstract][Full Text] [Related]
37. Residual platelet reactivity to predict long-term clinical outcomes after clopidogrel loading in patients with acute coronary syndromes: comparison of different cutoff values by light transmission aggregometry from the responsiveness to clopidogrel and stent thrombosis 2-acute coronary syndrome (RECLOSE 2-ACS) study.
Valenti R; Marcucci R; Capodanno D; De Luca G; Migliorini A; Gori AM; Parodi G; Giusti B; Carrabba N; Paniccia R; Cantini G; Marrani M; Gensini GF; Abbate R; Antoniucci D
J Thromb Thrombolysis; 2015 Jul; 40(1):76-82. PubMed ID: 25502874
[TBL] [Abstract][Full Text] [Related]
38. Effect of clopidogrel treatment on stress-induced platelet activation and myocardial ischemia in aspirin-treated patients with stable coronary artery disease.
Perneby C; Wallén NH; Hofman-Bang C; Tornvall P; Ivert T; Li N; Hjemdahl P
Thromb Haemost; 2007 Dec; 98(6):1316-22. PubMed ID: 18064330
[TBL] [Abstract][Full Text] [Related]
39. Relationship between diabetes, platelet reactivity, and the SYNTAX score to one-year clinical outcome in patients with non-ST-segment elevation acute coronary syndrome undergoing percutaneous coronary intervention.
De Servi S; Crimi G; Calabrò P; Piscione F; Cattaneo M; Maffeo D; Toso A; Bartorelli A; Palmieri C; De Carlo M; Capodanno D; Barozzi C; Tomasi L; Della Riva D; Angiolillo DJ; Palmerini T
EuroIntervention; 2016 Jun; 12(3):312-8. PubMed ID: 27320425
[TBL] [Abstract][Full Text] [Related]
40. Determinants of aspirin resistance in patients with type 2 diabetes.
Paven E; Dillinger JG; Bal Dit Sollier C; Vidal-Trecan T; Berge N; Dautry R; Gautier JF; Drouet L; Riveline JP; Henry P
Diabetes Metab; 2020 Oct; 46(5):370-376. PubMed ID: 31783142
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
